The Identification of Immunological Biomarkers in Kidney Cancers

The recent approval of several agents have revolutionized the scenario of therapeutic management of metastatic renal cell carcinoma (RCC) allowing us to reach important clinical end points with extended patients' survival. Actually, every new drug approved has represented an important step forw...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Oncol
Asıl Yazarlar: Lopez-Beltran, Antonio, Henriques, Vanessa, Cimadamore, Alessia, Santoni, Matteo, Cheng, Liang, Gevaert, Thomas, Blanca, Ana, Massari, Francesco, Scarpelli, Marina, Montironi, Rodolfo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2018
Konular:
Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6225533/
https://ncbi.nlm.nih.gov/pubmed/30450335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00456
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller